This observation is consistent with findings from Grigoriev et al.’s clinical study, where across more than 9000 subjects enrolled in the NWTS 1 to 5 trials, nearly half of the chronic kidney disease (CKD) patients had a WT1-associated mutation or congenital anomaly [98]. The gene discussed is WT1; the disease is chronic kidney disease.